title: Dynamic cardiomyoplasty as a therapeutic alternative: current status.
abstract: Dynamic cardiomyoplasty was proposed as an alternative surgical treatment for severe cardiomyopathies and has been performed worldwide in more than 1,000 patients. Patients indicated for this procedure are specifically those with dilated or ischemic cardiomyopathies. The ventricular function improvement observed after dynamic cardiomyoplasty derived from the direct action of synchronized skeletal muscle flap contraction and from a girdling effect that helps to reverse chamber remodeling and to decrease ventricular wall stress. Although long-term benefits of this procedure may be limited by skeletal muscle flap ischemic compromise, technological advances incorporated in the new myostimulators will possibly decrease this complication incidence. Clinical improvement has been reported as a consistent finding in cardiomyoplasty follow-up and the overall 5-year survival after this procedure ranges from 39 % to 54 %. On the other hand, the mortality after cardiomyoplasty has been significantly higher for patients in persistent New York Heart Association functional class IV, showing that this procedure needs to be indicated earlier than the heart transplantation. In this regard, only the results of an ongoing randomized trial will potentially define cardiomyoplasty influence on the survival of patients with severe heart failure. In the meantime, however, there are clearly several functional class III patients whose quality of life and exercise capacity have worsened despite the use of maximum medical therapy, justifying dynamic cardiomyoplasty indication.
authors.affiliation: Heart Institute (Incor), University of São Paulo Medical School, São Paulo, SP, Brazil. dcimoreira@incor.usp.br
authors.forename: L F
authors.initials: LF
authors.lastname: Moreira
authors.forename: N A
authors.initials: NA
authors.lastname: Stolf
mesh_terms: D009202:Cardiomyopathies / Q000401:mortality / Q000601:surgery*; D018421:Cardiomyoplasty; D006801:Humans; D016896:Treatment Outcome